Gene: C10orf88
Official Full Name: chromosome 10 open reading frame 88provided by HGNC
Gene Summary: Enables ATP hydrolysis activity. Predicted to be involved in chromatin looping and chromatin remodeling. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19213 | C10orf88 Knockout cell line (HeLa) | Human | C10orf88 | 1:3~1:6 | Negative | Online Inquiry |
KO19214 | C10orf88 Knockout cell line (HCT 116) | Human | C10orf88 | 1:2~1:4 | Negative | Online Inquiry |
KO19215 | C10orf88 Knockout cell line (HEK293) | Human | C10orf88 | 1:3~1:6 | Negative | Online Inquiry |
KO19216 | C10orf88 Knockout cell line (A549) | Human | C10orf88 | 1:3~1:4 | Negative | Online Inquiry |
C10orf88 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the comprehensive study of the C10orf88 gene, which is implicated in various biological processes and cellular functions. These cell lines are generated using CRISPR-Cas9 technology, which enables precise and targeted disruption of the C10orf88 gene, allowing researchers to observe the resultant phenotypic alterations and investigate the gene's role in specific pathways.
The primary function of C10orf88 Gene Knockout Cell Lines is to provide researchers with a tool to explore gene function, interactions, and potential implications in disease models. The knockout design effectively removes the gene’s influence, establishing a baseline for comparison with wild-type controls. This enables detailed analysis of cell behavior, signaling pathways, and potential compensatory mechanisms that may arise due to the gene's absence.
Scientifically, these cell lines are critical in various research applications including cancer biology, neurobiology, and developmental studies. They offer insights into genetic vulnerabilities and may guide therapeutic strategies in clinical settings. Moreover, the derived data can contribute to the understanding of complex diseases where C10orf88 is involved, aiding in the identification of novel targets for drug development.
Unlike alternative methods, such as RNA interference, which can lead to off-target effects and varying degrees of gene downregulation, our C10orf88 Gene Knockout Cell Lines provide a complete and stable gene loss, ensuring reproducibility and reliability in research findings. The precision of CRISPR technology promises enhanced specificity, minimizing unintended mutations, a crucial factor in rigorous scientific investigation.
For researchers and clinicians exploring the functional implications of the C10orf88 gene, these knockout cell lines represent an invaluable resource that drives innovation, facilitates breakthroughs, and enhances understanding of genetic contributions to disease. Our company is dedicated to advancing the field of genetic research and provides high-quality, validated products that cater to the evolving needs of the scientific community, underscoring our commitment to excellence in bioscience.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.